Protocol Title: A Phase III, Two- Arm, Parallel, Randomized, Multi-Center,Open-Label, Global
Study to Determine the Efficacy of Volrustomig (MEDI5752) Versus Pembrolizumab in
Combination
with Chemotherapy for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung
Cancer (mNSCLC) (eVOLVE-Lung02)
Protocol Number: (D798AC00001).
Metastatic Non-Small Cell Lung Cancer
